InvestorsHub Logo
Followers 0
Posts 2
Boards Moderated 0
Alias Born 06/25/2012

Re: jbog post# 17025

Saturday, 03/18/2017 12:08:22 PM

Saturday, March 18, 2017 12:08:22 PM

Post# of 20689
Does MNTA have any legal recourse against Sandoz for selecting Pfizer to fill/finish without properly examining their FDA manufacturing certification status? This mistake may cost MNTA upwards of a billion dollars if another firm's generic 40 mg gets approval to begin marketing before Pfizer can get their plant recertified.